Target intelligence / Profile preview

Cavernosal vascular and trabecular smooth muscle

Molecular classification
Smooth muscle
01

Overview

Cavernosal vascular and trabecular smooth muscle forms the core structural and functional component within the corpora cavernosa of the penis, consisting of interwoven smooth muscle cells in trabeculae that surround endothelial-lined sinusoids and lacunar spaces. During sexual arousal, parasympathetic stimulation triggers nitric oxide (NO) release from endothelial and neuronal sources, leading to smooth muscle relaxation, helicine artery dilation, and blood influx that expands the sinusoids, compresses subtunical venules against the tunica albuginea, and traps blood to produce a rigid erection via veno-occlusion. This muscle is supported by intracavernosal pillars and the bilayered tunica albuginea, with skeletal muscles like the ischiocavernosus and bulbospongiosus contributing to rigidity and venous compression. In disease, dysfunction arises from impaired relaxation due to endothelial damage, reduced NO synthase activity, or conditions like diabetes, hypertension, and atherosclerosis, resulting in erectile dysfunction (ED), the inability to achieve or sustain erection. Therapeutically, PDE5 inhibitors such as sildenafil enhance cGMP signaling downstream of NO to restore relaxation, making this smooth muscle a key target for ED pharmacotherapy, though challenges include off-target vasodilation effects.

Other names
Corpus cavernosum smooth muscleCavernosal smooth muscleTrabecular smooth muscle
02

Mechanism of action

PDE5 inhibition increases cGMP to promote smooth muscle relaxation and NO-mediated vasodilation NO-mediated relaxation of smooth muscle via endothelial and neuronal NOS

03

Biological functions

Vascular smooth muscle relaxation for penile erectionBlood trapping via veno-occlusionSinusoidal expansion
04

Disease associations

Erectile dysfunction
05

Safety considerations

Hypotension from systemic vasodilationPriapism from prolonged relaxationVisual disturbances or headache with PDE5 inhibitors
06

Interacting drugs

Sildenafil (PDE5 inhibitor)

2 more in the full profile.

Beyond the preview

Go deeper on Cavernosal vascular and trabecular smooth muscle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cavernosal vascular and trabecular smooth muscle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call